Publication | Open Access

Antitumor action of CDK inhibitor LS-007 as a single agent and in combination with ABT-199 against human acute leukemia cells

Hematological MalignancyTumor BiologyCdk Inhibitor Ls-007Single AgentMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyPharmacologyAntitumor ActionAnti-cancer AgentAdult T-cell Leukemia-lymphomaImmunotherapyOncologyCancer Research